학술논문
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
Document Type
Article
Author
Source
In: Frontiers in Pharmacology . (Frontiers in Pharmacology, 2023, 14)
Subject
Language
English
ISSN
16639812